Page last updated: 2024-08-22

deuterium and npi 2358

deuterium has been researched along with npi 2358 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, H; Ding, Z; Guan, H; Hou, Y; Li, W; Wang, S; Zhao, J1
Ding, Z; Guan, H; Hou, Y; Li, W; Ma, M; Sun, T; Wang, S1
Cheng, H; Deng, M; Ding, Z; Dou, G; Hou, Y; Li, F; Li, W; Ma, M; Zhao, J1
Ding, Z; Li, W; Li, Z; Ma, L; Ma, M; Wang, S; Wang, Y; Yang, J; Zhong, L1

Other Studies

4 other study(ies) available for deuterium and npi 2358

ArticleYear
Development of MBRI-001, a deuterium-substituted plinabulin derivative as a potent anti-cancer agent.
    Bioorganic & medicinal chemistry letters, 2017, 03-15, Volume: 27, Issue:6

    Topics: Animals; Antineoplastic Agents; Area Under Curve; Cell Line; Deuterium; Diketopiperazines; Humans; Mice; Models, Molecular; Rats; Xenograft Model Antitumor Assays

2017
Synthesis of deuterium-enriched and fluorine-substituted plinabulin derivatives and evaluation of their antitumor activities.
    Molecular diversity, 2017, Volume: 21, Issue:3

    Topics: Antineoplastic Agents; Carbon-13 Magnetic Resonance Spectroscopy; Cell Proliferation; Cell Survival; Deuterium; Diketopiperazines; Fluorine; Humans; Jurkat Cells; Mass Spectrometry; Molecular Structure; Proton Magnetic Resonance Spectroscopy

2017
In vitro and in vivo pharmacokinetic and pharmacodynamic study of MBRI-001, a deuterium-substituted plinabulin derivative as a potent anti-cancer agent.
    Bioorganic & medicinal chemistry, 2018, 09-01, Volume: 26, Issue:16

    Topics: Animals; Antineoplastic Agents; Blood Proteins; Cell Line, Tumor; Cytochrome P-450 Enzyme System; Deuterium; Diketopiperazines; Female; Half-Life; Humans; Inhibitory Concentration 50; Male; Mice; Mice, Inbred BALB C; Microsomes, Liver; Neoplasms; Protein Binding; Rats; Rats, Wistar; Tissue Distribution

2018
Polymorphs, co-crystal structure and pharmacodynamics study of MBRI-001, a deuterium-substituted plinabulin derivative as a tubulin polymerization inhibitor.
    Bioorganic & medicinal chemistry, 2019, 05-01, Volume: 27, Issue:9

    Topics: Animals; Binding Sites; Cell Line, Tumor; Cell Survival; Crystallography, X-Ray; Deuterium; Diketopiperazines; Humans; Mice; Mice, Nude; Molecular Conformation; Molecular Dynamics Simulation; Neoplasms; Protein Structure, Tertiary; Tubulin; Tubulin Modulators

2019